反映胸腺功能保留的生物标志物谱与接受抗逆转录病毒治疗且病毒控制良好的老年HIV感染者合并症减少相关:AGEhIV队列分析
在AGEhIV队列中,对94例接受抗逆转录病毒治疗且病毒控制良好的HIV感染者和95例无HIV对照者基于基线免疫、炎症及衰老生物标志物进行潜在谱分析,识别出三种生物标志物谱。仅HIV状态与谱归属显著相关,HIV感染者相比对照者更常呈现高胸腺输出/低炎症谱;在HIV感染者中该谱与随访中位8.0年期间显著更低的平均合并症数相关,而对照者中未见此关联。
要点
- HIV感染者较无HIV对照者更常呈现高胸腺输出/低炎症生物标志物谱。
- 在HIV感染者中,高胸腺输出/低炎症谱与随访期间显著更低的平均合并症数相关。
- 在无HIV对照者中,未观察到该谱与合并症的显著关联。
核心结论
- 接受抗逆转录病毒治疗且病毒控制良好的老年HIV感染者相比无HIV对照者更可能呈现反映胸腺功能保留和慢性炎症较少的生物标志物谱。
- 具有该谱的HIV感染者似乎相对不易发生衰老相关合并症。
研究设计与样本
- AGEhIV队列分析,纳入94例接受抗逆转录病毒治疗且病毒控制良好的HIV感染者和95例无HIV对照者。
- 采用潜在谱分析基于基线选定的免疫、炎症和衰老生物标志物构建生物标志物谱。
- 采用多变量logistic回归评估与谱归属相关的因素,采用Poisson回归按HIV状态分层评估谱与随访期间平均总合并症数的关联。
主要发现
- 识别出三种生物标志物谱:高胸腺输出/低炎症谱(HIV感染者n=27,对照者n=9)、低胸腺输出/高炎症谱(HIV感染者n=29,对照者n=26)和中间谱(HIV感染者n=38,对照者n=60)。
- 仅HIV状态与谱归属显著相关,HIV感染者相对于对照者更常呈现高胸腺输出/低炎症谱而非其他谱。
- 在HIV感染者中而非对照者中,高胸腺输出/低炎症谱与随访中位8.0年(四分位距7.1-8.1年)期间显著更低的平均合并症数相关。
关键数值与推荐
- 合并症包括2型糖尿病、非艾滋病恶性肿瘤、心血管疾病、骨质疏松、慢性肾脏病和衰弱。
- 高胸腺输出/低炎症谱:HIV感染者n=27,对照者n=9;低胸腺输出/高炎症谱:HIV感染者n=29,对照者n=26;中间谱:HIV感染者n=38,对照者n=60。
- 随访中位8.0年(四分位距7.1-8.1年)。
- 临床试验注册号NCT01466582。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with HIV (PWH) experience a higher burden of aging-associated comorbidities, the underlying mechanisms of which remain to be fully elucidated. We aimed to identify profiles based on immune, inflammatory, and aging biomarkers in blood from PWH and controls, and explore their association with total comorbidities over time. METHODS: Latent profile analysis was used to construct biomarker profiles in AGEhIV cohort participants (94 with well-controlled HIV on antiretroviral therapy [ART] and 95 controls without HIV) using baseline measurements of selected biomarkers. Factors associated with profile membership were assessed by multivariable logistic regression. The association between profiles and mean total comorbidities during follow-up was assessed by Poisson regression, stratified by HIV status. Comorbidities included type 2 diabetes, non-AIDS malignancies, cardiovascular disease, osteoporosis, chronic kidney disease. and frailty. RESULTS: Three biomarker profiles were identified: "high thymic output/low inflammation" (HT/LI) profile (n = 27 PWH, n = 9 controls), "low thymic output/high inflammation" (LT/HI) profile (n = 29 PWH, n = 26 controls), and an "intermediate" profile (n = 38 PWH, n = 60 controls). Only HIV status was significantly associated with profile membership. PWH, relative to controls, more often exhibited the HT/LI profile compared to other profiles. In PWH, but not in controls, the HT/LI profile was associated with significantly lower mean comorbidities during a median 8.0 years (interquartile range, 7.1-8.1) of follow-up. CONCLUSIONS: People aging with well-controlled HIV on ART were more likely to exhibit a biomarker profile indicative of preserved thymic function and less chronic inflammation compared to controls. PWH with such a profile seemed relatively protected from developing aging-associated comorbidities. CLINICAL TRIALS REGISTRATION: NCT01466582.
引用
- Vanbellinghen MC, Boyd A, Kootstra NA, et al. A Biomarker Profile Reflective of Preserved Thymic Function Is Associated With Reduced Comorbidities in Aging People With HIV: An AGEhIV Cohort Analysis. J Infect Dis. 2025. PMID: 39658325. doi:10.1093/infdis/jiae603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。